Response to: ‘Correspondence on ‘EULAR definition of difficult-to-treat rheumatoid arthritis’’ by Novella-Navarro et al

@article{Roodenrijs2020ResponseT,
  title={Response to: ‘Correspondence on ‘EULAR definition of difficult-to-treat rheumatoid arthritis’’ by Novella-Navarro et al},
  author={Nadia M T Roodenrijs and Paco M. J. Welsing and Marlies C. van der Goes and Johannes W.G. Jacobs and D{\'e}sir{\'e}e Mfm van der Heijde and J M van Laar and Gy{\"o}rgy Nagy},
  journal={Annals of the Rheumatic Diseases},
  year={2020}
}
We read with great interest the correspondence of Novella-Navarro et al on our paper regarding the European League Against Rheumatism (EULAR) definition of difficult-to-treat rheumatoid arthritis (D2T RA).1 2 We appreciate their acknowledgement of the need for uniform terminology and a uniform definition to describe the concept of D2T RA. Previously, this need had also been underlined by rheumatologists participating in an international survey.3 The use of heterogeneous terminology and… Expand

References

SHOWING 1-10 OF 16 REFERENCES
Correspondence on: ‘EULAR definition of difficult-to-treat rheumatoid arthritis’
TLDR
The definition of difficult-to-treat rheumatoid arthritis was established and ‘multi-refractory’ patients were defined as those who have received biologic disease-modifying antirheumatic drugs with different mechanism of action or ≥3 bDMARDs with the same target. Expand
EULAR definition of difficult-to-treat rheumatoid arthritis
TLDR
The proposed EULAR definition for difficult-to-treat RA can be used in clinical practice, clinical trials and can form a basis for future research. Expand
FRI0047 STRATEGIES REGARDING GOAL SETTING AND SELF-MANAGEMENT IN DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS: PRELIMINARY RESULTS OF A SYSTEMATIC LITERATURE REVIEW INFORMING THE 2020 EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS
TLDR
The Arthritis Self-Efficacy Score was found to be the most reliable tool to identify suboptimal self- management and patients were found to desire more education on nutrition, the disease and the diagnostic process to be able to improve self-management. Expand
SAT0052 THERAPEUTIC STRATEGIES IN DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS: PRELIMINARY RESULTS OF A SYSTEMATIC LITERATURE REVIEW INFORMING THE 2020 EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS
TLDR
In patients with predominantly non-inflammatory complaints, exercise, education, psychological and self-management interventions were found to be of additional benefit and the scarcity of evidence on the optimal treatment of difficult-to-treat RA patients was underscored. Expand
Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey
Objectives Patients with difficult-to-treat rheumatoid arthritis (RA) remain symptomatic despite treatment according to current European League Against Rheumatism (EULAR) management recommendations.Expand
Response to ’Correspondence to viewpoint ’Defining refractory rheumatoid arthritis' by Buch' by Roodenrijs et al
  • M. Buch
  • Medicine
  • Annals of the rheumatic diseases
  • 2018
TLDR
The authors highlight their description and recent review of ‘difficult to treat RA’ that in contrast to my viewpoint includes refractory rheumatoid arthritis (RA) in the presence of persistent inflammation and in its absence. Expand
Correspondence to viewpoint ‘Defining refractory rheumatoid arthritis’ by Buch
TLDR
The author highlights the gap of knowledge in the understanding of refractory RA and states that consistent definitions and criteria are required for future research. Expand
Difficult-to-treat rheumatoid arthritis: an area of unmet clinical need.
TLDR
It is argued that difficult-to-treat RA constitutes an area of unmet clinical need and a definition of this concept is proposed and an approach towards improved patient-tailored management is presented. Expand
Clinical predictors of multiple failure to biological therapy in patients with rheumatoid arthritis
TLDR
This study supports the contention that younger patients with erosive disease and especially the early absence of clinical response to the first bDMARDs are predictors of multi-refractoriness to consecutive biologics. Expand
Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
TLDR
This first national study has identified the frequency of bDMARD refractory disease to be at least 6% of patients who have ever received rheumatoid arthritis treatment, and identified baseline clinical factors associated with refracted disease. Expand
...
1
2
...